| THE NEW IMPROVED E. COLI IS MUCH MORE DEADLY
says UKs Health Protection Agency
Note from the webmaster:
Genetic transfer of antibiotic resistant genes from species to species during the treatment of sewage sludge has
been documented for over 40 years. The pathogen contaminated sludge biosolids is then spread on food crops,
parks and home lawns, even though the evidence of E. coli (fecal coliform test) in the sludge is used to prove its
Infections caused by ESBL-producing E. coli
Published: Monday, 24-Sep-2007
In light of increased media and public interest in ESBL-producing E. coli, the UK's Health Protection Agency felt it
would be helpful to provide some background about these infections and the work that is being carried out in this
ESBL (Extended-Spectrum Beta-Lactamase)-producing E. coli are antibiotic-resistant strains of E. coli. E. coli are
very common bacteria that normally live harmlessly in the gut. ESBL-producing strains produce an enzyme called
extended-spectrum beta lactamase, which makes them more resistant to cephalosporin antibiotics. Many
ESBL-producing strains are also resistant to antibiotics belonging to other classes. This makes the infections harder
The kinds of infections that ESBL-producing E. coli can cause range from urinary tract infections, to - at the more
serious end of the spectrum - cases where they enter the bloodstream and cause blood poisoning. Infections with
ESBL-producing E. coli are most common amongst the elderly, or those who have recently been in hospital or
received antibiotic treatment. ESBL-producing E. coli are extremely rare in simple cystitis.
Infections caused by ESBL-producing E. coli are a growing worldwide phenomenon and are not unique to the UK .
The Health Protection Agency is one of the leading institutions worldwide in terms of research into this area and has
been providing advice about these infections for many years and, in particular, produced a report on the increasing
frequency of these infections in 2005.
Since 2003 the Agency has been working with NHS hospital microbiologists to ensure they are aware of these
infections and are able to advise and provide information to their local GPs and hospitals about the diagnosis and
treatment of these infections. The Agency has also published a lot of information in scientific journals and issued
advice directly to GPs via its website and leaflets. It also continues to review the activity of new antibiotics against
bacteria with these enzymes.
A lot of research still needs to be carried out into the origin of the strains of E. coli that cause infections. Imported
chicken has been suggested as a possible route for their introduction into the UK . However recent HPA research
shows that the particular strains of E. coli and the particular ESBLs that they produce are significantly different from
those so far found in chickens, so this link remains unproven. This research detected E. coli with the ESBLs
CTX-M-1; CTX-M-2 and CTX-M-14 in imported chicken meat; however most of the ESBL-producing E.coli from
human infections have the CTX-M-15 ESBL which was not found in any chicken samples.
A second theory for the origin of these infections, which also requires more research, is that migration could be a
source. More research is needed on other aspects too, such as the number of people who carry ESBL-producing E.
coli in their gut, though it should be stressed that most of these will be carrying it harmlessly, and it will not cause
them any illness.
The figure being quoted in the media of 30,000 cases of infection due to ESBL-producing E. coli each year in the
UK is an estimate. This estimate takes into account all cases, whether they cause urinary tract infections or blood
poisoning; however this estimate still needs to be verified.
The Agency's monitoring shows that around 20,000 people a year in the UK (excluding Scotland ) are affected by
blood poisoning caused by E. coli . Of these, around 2,000 cases are caused by ESBL-producing E. coli (these
figures cover blood poisoning only and not urinary tract infections). The Agency will be widening this surveillance
system shortly and its eight regional laboratories will be carrying out surveillance of ESBLs in other types of infection
(e.g. urinary infections) so that a more complete picture of numbers and trends can be established. Any introduction
of mandatory surveillance, as we currently have for MRSA or C difficile, would be the responsibility of the
Department of Health.
For further information about ESBL-producing E.coli go to: http://www.hpa.org.uk/infections/topics_az/esbl/